Cite
HARVARD Citation
Walker, I. et al. (2020). Addition of anti-thymocyte globulin to standard graft-versus-host disease prophylaxis versus standard treatment alone in patients with haematological malignancies undergoing transplantation from unrelated donors: final analysis of a randomised, open-label, multicentre, phase 3 trial. Lancet. 7 (2), pp. e100-e111. [Online].